Nektar Therapeutics (NKTR) Q3 2023 Earnings Call Transcript
Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Vivian Wu - Director, ...
Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Vivian Wu - Director, ...
Drew Angerer/Getty Images News Bristol-Myers Squibb (NYSE:BMY) agreed to purchase cancer drug maker Mirati Therapeutics (NASDAQ:MRTX) for about $4.8 billion. ...
McDonald's french fries being prepared.Daniel Acker | Bloomberg | Getty ImagesCheck out the companies making headlines in midday trading.Rivian Automotive ...
Milko Maintaining a Buy Rating for Structure Therapeutics Following the Positive Clinical Data Readout of GSBR-1290 In the fast-evolving world ...
D3Damon/E+ via Getty Images Overview of the thesis Rani Therapeutics (NASDAQ:RANI) is developing a robotic pill to allow oral delivery ...
koto_fejaOverview of the thesis Brainstorm Cell Therapeutics (NASDAQ:BCLI) is developing cellular therapies for neurodegenerative diseases. BCLI has completed a phase ...
chemicalbillyI covered Stoke Therapeutics (NASDAQ:STOK) in February, and although I was mildly positive, I am lucky I didn’t go out ...
© Reuters. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, ...
© Reuters (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Biogen (NASDAQ:) and Sage Therapeutics' oral pill ...
RyanJLane/E+ via Getty ImagesI covered G1 Therapeutics (NASDAQ:GTHX) in November, when they were talking about when to topline their colorectal ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.